The Large Cap Sustainable Growth Strategy traded down for Q1 2026, underperforming its benchmark, the Russell 1000® Growth ...

Review authors suggested guidelines to help in standardizing future lupus nephritis studies. Heterogeneity in lupus nephritis (LN) trial design substantially hinders interpretation of studied drugs’ ...

Bitcoin price breaks $81,000, fueled by record ETF inflows and a supply shock that sees institutions buying 500% of mined supply.

During the quarter, Heartland Opportunistic Value Equity Strategy returned 3.66%, outperforming the Russell 3000® Value Index ...

Bempikibart 36-week topline data readout from Part B of SIGNAL-AA Phase 2a clinical trial on-track for mid-2026 -- -- First patient dosed in SIGNAL-AA Part B open-label ...

Credit: IGN Nintendo of America's former president Reggie Fils-Aimé has addressed the failure of Wii U, which he blamed on ...

Australia: A clinical feasibility study published in the Journal of Diabetes Science and Technology has found that an ...

These findings are important because they suggest that more selective JAK inhibition, particularly targeting JAK1 or JAK2, can effectively reduce organ pathology and pathogenic IFN-γ-producing immune ...

SCIEX, a Danaher company and leader in life science analytical technologies, highlighted six industry collaborations as it continues to build an integrated software environment with SCIEX software ...

Creatine, a compound often associated with gym-goers and athletes, has long been touted as a performance-enhancing supplement ...

Semiconductor stocks have surged to parabolic levels, fueled by a wave of earnings 'triple plays' from major tech firms that beat forecasts and raised guidance. While momentum remains strong, ...

The moment you step into Rhea Sycip’s Flour Pot in BGC, the word that will pop into your mind—at the risk of being called a ...